日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction to: Diacerein improves liver fibrosis, steatosis, and atherosclerosis in ApoE knockout mice

更正:双醋瑞因改善ApoE基因敲除小鼠的肝纤维化、脂肪变性和动脉粥样硬化

Lee, Jie-Eun; Jin, Isom; Lee, Jung-Jae; Jung, Jisu; Lee, Jee-In; Kim, Bo-Rahm; Oh, Tae Jung; Lee, Yun Kyung; Choi, Sung Hee

Diacerein improves liver fibrosis, steatosis, and atherosclerosis in ApoE knockout mice

双醋瑞因可改善ApoE基因敲除小鼠的肝纤维化、脂肪变性和动脉粥样硬化

Lee, Jie-Eun; Jin, Isom; Lee, Jung-Jae; Jung, Jisu; Lee, Jee-In; Kim, Bo-Rahm; Oh, Tae Jung; Lee, Yun Kyung; Choi, Sung Hee

Upregulation of the serine palmitoyltransferase subunit SPTLC2 by endoplasmic reticulum stress inhibits the hepatic insulin response

内质网应激上调丝氨酸棕榈酰转移酶亚基SPTLC2可抑制肝脏胰岛素反应。

Kim, Goon-Tae; Devi, Shivani; Sharma, Amitesh; Cho, Kyung-Hee; Kim, Su-Jung; Kim, Bo-Rahm; Kwon, Sang-Ho; Park, Tae-Sik

The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice.

重组人白细胞介素-1受体拮抗剂阿那白滞素在载脂蛋白E敲除小鼠中的抗动脉粥样硬化作用

Ku Eu Jeong, Kim Bo-Rahm, Lee Jee-In, Lee Yun Kyung, Oh Tae Jung, Jang Hak C, Choi Sung Hee

The Effects of PPAR Agonists on Atherosclerosis and Nonalcoholic Fatty Liver Disease in ApoE-/-FXR-/- Mice

PPAR激动剂对ApoE-/-FXR-/-小鼠动脉粥样硬化和非酒精性脂肪肝疾病的影响

Lee, Yenna; Kim, Bo-Rahm; Kang, Geun-Hyung; Lee, Gwan Jae; Park, Young Joo; Kim, Haeryoung; Jang, Hak Chul; Choi, Sung Hee

Circulating sortilin level as a potential biomarker for coronary atherosclerosis and diabetes mellitus

循环分选蛋白水平作为冠状动脉粥样硬化和糖尿病的潜在生物标志物

Oh, Tae Jung; Ahn, Chang Ho; Kim, Bo-Rahm; Kim, Kyoung Min; Moon, Jae Hoon; Lim, Soo; Park, Kyong Soo; Lim, Cheong; Jang, HakChul; Choi, Sung Hee

Sphingolipid metabolism and obesity-induced inflammation

鞘脂代谢与肥胖引起的炎症

Kang, Se-Chan; Kim, Bo-Rahm; Lee, Su-Yeon; Park, Tae-Sik

NdgR, a common transcriptional activator for methionine and leucine biosynthesis in Streptomyces coelicolor

NdgR 是天蓝色链霉菌中蛋氨酸和亮氨酸生物合成的常见转录激活因子

Songhee H Kim, Bo-Rahm Lee, Ji-Nu Kim, Byung-Gee Kim